Reversible cross-linked biodegradable polymer vesicles with asymmetric membrane structure and its preparation method and application in nucleic acid medicine

A technology for degrading polymers and membrane structures, which can be used in medical preparations without active ingredients, medical preparations containing active ingredients, and drug combinations, etc. It can solve the problems of instability in the body, poor targeting, and high cytotoxicity. Achieve the effect of avoiding losses and toxic side effects, solving disease problems, and efficient migration

Active Publication Date: 2019-01-18
SUZHOU UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, studies have found that existing PEI vectors have the defects of high gene recombination and transfection efficiency but high cytotoxicity, and low cytotoxicity but poor gene recombination and transfection efficiency.
The research results of using nanocarriers such as liposomes and polyion complexes containing cations to load nucleic acids are not satisfactory. There are instability in vivo, poor targeting, low gene complex and transfection efficiency, and there are still cells. toxicity problem
Currently there is no solution that can solve these problems at the same time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Reversible cross-linked biodegradable polymer vesicles with asymmetric membrane structure and its preparation method and application in nucleic acid medicine
  • Reversible cross-linked biodegradable polymer vesicles with asymmetric membrane structure and its preparation method and application in nucleic acid medicine
  • Reversible cross-linked biodegradable polymer vesicles with asymmetric membrane structure and its preparation method and application in nucleic acid medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Example 1 Synthesis of PEG5k-P(DTC4.4k-TMC19.8k)-bPEI1.8k block copolymer

[0084] The synthesis of PEG5k-P(DTC4.4k-TMC19.8k)-bPEI is divided into two steps, the first is ring-opening polymerization to prepare PEG5k-P(DTC4.4k-TMC19.8k) diblock copolymer, the specific operation is as follows, in In the nitrogen glove box, weigh MeO-PEG-OH ( M n = 5.0 kg / mol, 0.50 g, 100 μmol), TMC (2.0 g, 19.2 mmol) and DTC (0.50 g, 2.60 mmol) were dissolved in dichloromethane (DCM, 7.0 mL), and the ring-opening polymerization catalyst bis Zinc (bistrimethylsilyl)amine (29 mg, 75 μmol). The airtight reactor was sealed and placed under magnetic stirring in an oil bath at 40 °C for 2 days. After terminating the reaction with glacial acetic acid, precipitate twice in glacial ether, filter with suction, and dry under vacuum at room temperature to obtain PEG5k-P (DTC4.4k-TMC19.8k).

[0085] Next, PEG5k-P (DTC4.4k-TMC19.8k) was activated by p-nitrophenyl hydroxychloroformate NPC, and then...

Embodiment 2

[0087] Example 2 Synthesis of Mal-PEG6k-P (DTC4.8k-TMC19.2k)-lPEI1.2k block copolymer

[0088] The synthesis of Mal-PEG6k-P(DTC4.8k-TMC19.2k)-lPEI1.2k is similar to embodiment one, also is divided into two steps, just the initiator MeO-PEG-OH in the first step wherein is changed to Maleimide-functionalized Mal-PEG6k-OH, ring-opening polymerization of TMC and DTC to obtain Mal-PEG6k-P (DTC4.8k-TMC19.2k), whose terminal hydroxyl groups were activated with NPC, and then combined with linear PEI (lPEI) primary amine ( M n =1.2 kg / mol) reaction. The specific operation was similar to that of Example 1, the product was precipitated twice in glacial ether, filtered with suction and dried under vacuum at room temperature to obtain the product. Yield: 93.2%. 1 H NMR (400 MHz, DTCl 3 ): PEG: δ 3.38, 3.65; TMC: δ 4.24, 2.05; DTC: δ 4.32, 3.02, PEI: δ 2.56-2.98. The number average molecular weight of the polymer is calculated as 6.0-(4.8-19.2)-1.2 kg / mol through the integral ratio of...

Embodiment 3

[0089] Example 3 Synthesis of cNGQ-PEG7k-P (DTC4.8k-TMC19.2k) diblock copolymer

[0090]The synthesis of cNGQ-PEG7k-P (DTC2.8k-TMC14.2k) is similar to Example 1, and it is also divided into two steps. The initiator MeO-PEG-OH in the first step is replaced by N-hydroxysuccinimide Functionalized NHS-PEG-OH, ring-opening polymerization of TMC and DTC to obtain NHS-PEG7k-P (DTC4.8k-TMC19.2k); secondly, peptide C(NGQGEQ) (cNGQ) with free primary amines combined with NHS-PEG7k -P(DTC4.8k-TMC19.2k) is bonded by amidation reaction. Briefly, NHS-PEG7k-P(DTC4.8k-TMC19.2k) (0.5 g, 0.017 mmol) and cNGQ (20 mg, 0.033 mmol) were successively dissolved in 5 mL DMF, reacted at room temperature for 2 days, and then dialyzed in distilled water After two days (MWCO 3500), freeze-dry to obtain the product cNGQ-PEG7k-P (DTC4.8k-TMC19.2k). Yield: 81.2%. 1 H NMR (400 MHz, DMSO- d 6 ): PEG: δ 3.51; TMC: δ 4.23, 1.94; DTC: δ 4.13, 2.99; cNGQ: δ 6.84–7.61. The grafting rate of cNGQ measured by BC...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
degree of graftingaaaaaaaaaa
Login to view more

Abstract

The invention discloses a reversible cross-linked biodegradable polymer vesicle with an asymmetric membrane structure, a preparation method thereof and an application in nucleic acid medicine. Synthesized triblock polymer PEG-P(TMC-DTC)-PEI, PEG-P(DLLA-DTC)-PEI self-assembled and self-crosslinked to obtain polymersomes with asymmetric membrane structure, or connected with Targeted RCCPs are self-assembled by targeting molecules, the inner shell is PEI for complexing and loading nucleic acids through electrostatic interaction; the membrane is reversibly cross-linked biodegradable and biocompatible polyester / polycarbonate, side chain The dithiolane is similar to the human body's natural antioxidant lipoic acid, and the outer shell is based on PEG, which can target cancer cells. To study carrier complex functional siRNA, its in vivo and in vitro gene silencing effects, in vivo blood circulation and biodistribution, treatment of mice bearing orthotopic lung cancer and toxic and side effects, it is expected to become a simple, stable, multifunctional nano System platform for efficient, active targeted delivery of siRNA to tumors in situ.

Description

technical field [0001] The invention belongs to the drug carrier technology, and specifically relates to a reversibly cross-linked biodegradable polymer vesicle with an asymmetric membrane structure, a preparation method thereof, and an application in nucleic acid drug delivery. Background technique [0002] Gene therapy refers to the process of delivering genes with specific functions to specific tissue cells of organisms through certain methods to treat diseases. A variety of genetic diseases can be cured by using a variety of disease-causing genes that have been accurately identified to replace diseased genes in tissue cells or inhibit the expression of diseased genes; it is also possible to promote the synthesis and regulation of intracellular proteins by delivering functional genes Toxic protein or prodrug activating enzyme synthesis for the treatment of non-genetic diseases. However, gene drugs are easily degraded by nucleases in serum, and have poor ability to enter ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/59A61K48/00A61K31/713A61K9/127A61P35/00C08G81/02
CPCA61K9/1273A61K31/713A61K48/0041A61K48/0058A61K47/59C08G81/027C08G2230/00
Inventor 孟凤华邹艳杨炜静孟浩钟志远
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap